期刊文献+

不同链长聚乙二醇修饰的香豆素6脂质纳米粒对口服吸收的影响 被引量:3

Effects of polyethylene glycol length on oral absorption of coumarin 6-loaded nanostructured lipid carrier
下载PDF
导出
摘要 通过制备不同链长聚乙二醇(PEG)修饰的纳米脂质载体(NLCs)考察PEG链长对其口服吸收的影响。使用聚乙二醇(100)单硬脂酸酯(S100)、聚乙二醇(55)单硬脂酸酯(S55)、聚乙二醇(40)单硬脂酸酯(S40)3种不同链长的PEG通过薄膜分散法制备NLCs,以香豆素6(coumarin 6)作为荧光探针,对修饰不同链长PEG的NLCs进行理化性质表征。考察了不同链长PEG修饰的NLCs在模拟缓冲液中的稳定性以及体外释药行为。同时对NLCs的细胞毒性、细胞摄取动力学以及摄取机制进行了考察。结果表明,随着PEG链段长度的增加,其水化层厚度不断增大。与其他NLCs相比,S100修饰的NLCs(pNLC-EG100)具有更好的细胞摄取效率,证明S100的链段长度是用于口服NLCs给药的最佳长度。 Polyethylene glycol(PEG)of different lengths were prepared to investigate their effects on oralabsorption of nanostructured lipid carrier(NLCs).Three kinds of PEG-modified NLCs with different chainlengths,including polyethylene glycol(100)monostearate(S100),polyethylene glycol(55)monostearate(S55),polyethylene glycol(40)monostearate(S40),were prepared by film dispersion method.Coumarin 6 was chosen asa fluorescent probe to characterize the physicochemical properties of NLCs with different lengths.Meanwhile,thestability of NLCs in simulate buffer,the release behavior,cytotoxicity of NLCs,the uptake kinetics and cellularuptake mechanisms were evaluated.This work demonstrated that the thickness of the hydrated layer increasedwith the increase of PEG length.Of note,S100-modified NLCs(p NLC-EG100)exhibited higher cellular uptakeefficiency compared with other formulations.Thus,S100 was optimized as the best molecular weight for PEGmodified NLCs on oral drug delivery system.
作者 戴江东 李会鹏 孙敏捷 DAI Jiangdong;LI Huipeng;SUN Minjie(Jiangsu Jianhu People's Hospital,Yancheng 224700;Department of Pharmaceutics,China Pharmaceutical University,Nanjing 210009,China)
出处 《中国药科大学学报》 CAS CSCD 北大核心 2021年第3期293-300,共8页 Journal of China Pharmaceutical University
基金 国家自然科学基金资助项目(No.81872817) 中国药科大学“双一流”大学建设资助项目(No.CPU2018GY07)。
关键词 脂质纳米载体 PEG修饰 香豆素6 PEG链长 细胞摄取 口服吸收 nanostructured lipid carriers PEG modification coumarin 6 PEG length cell uptake oral absorption
  • 相关文献

参考文献2

二级参考文献17

  • 1Patel VF,Liu F, Brown MB. Advances in oral transmucosal drug delivery [ J ]. J Control Release,2011,153 (2) : 106 - 116.
  • 2Ensign LM,Cone R, Hanes J. Oral drug delivery with polymeric nanoparticles:the gastrointestinal mucus barriers [ J ]. Adv Drug Deliver Rev,2012,64 ( 6 ) :557 - 570.
  • 3Schenk M, Mueller C. The mucosal immune system at the gastro- intestinal barrier[ J ]. Best Pract Res Clin Gastroenterol,2008,22 (6) :391 -409.
  • 4Yuan H, Wang LL, Du YZ,et al. Preparation and characteristics of nanostroctured lipid carriers for control-releasing progesterone by meh-emulsiflcation [ J ]. Colloid Surface B, 2007,60 ( 2 ) : 174 - 179.
  • 5Jung T, Kamm W, Breitenbach A,et al. Biodegradable nanoparti- des for oral delivery of peptides: is there a role for polymers to af- fect mucosal uptake[J] ? Eur J Pharm Biopharm,2000,50( 1 ) : 147 - 160.
  • 6Des Rieux A, Ragnarsson EGE, GullbergE, et al. Transport of nanopartieles across an in vitro model of the human intestinal fol- licle associated epithelium [ J ]. Eur J Pharm Sci, 2005,25 ( 4/ 5 ) :455 - 465.
  • 7Jashi M,Patravale V. Nanostructured lipid cartier (NLC) based gel of celecoxib[ J]. lnt J Pharm,2008,346(1/2) :124 - 132.
  • 8Albanese A, Tang PS, Chan WCW. The effect of nanoparticle size,shape,and surface chemistry on biological systems[ J]. Annu Rev Biomed Eng,2012,14 : I - 16.
  • 9Muller RH, Petersen RD, HornmossA, et aL Nanostructured lipid carriers ( NLC ) in cosmetic dermal products[ J ]. Adv Drug Deliver Rev, 2007,59 ( 6 ) :522 - 530.
  • 10Chen HB, Zheng Y, Tian G, et al. Oraldelivery of DMAB-modi- fled docetaxel-loaded PLGA-TPGS nanoparticles for cancer chem- otherapy[J]. Nanoscale Res Lett,2011,6( 1 ) :4.

共引文献6

同被引文献44

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部